Danaher Corporation (DHR) Stock Price Today
Aura AI Summary
Key Stats
- $166.59BMarket Cap
- 2,697,481Volume
- HealthSector
- $242.0552W High
- $161.9152W Low
- 69 DaysTypical Hold Time
- $187.39BEnterprise Value
- 0.68%Div Yield
- 97% Sell | 3% BuyTrading Activity
Track Danaher Corporation (DHR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Danaher Corporation has traded between a low of $161.91 and a high of $242.05, highlighting its annual price range. Buy and sell Danaher Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Most Recent News
3E Network faces Nasdaq delisting over low share price, plans hearing to appeal and regain compliance.
3E Network Technology Group Limited received a notice from Nasdaq that its Class A shares will be delisted due to the share price falling below $1.00 for 30 consecutive business days. The company is not eligible for a compliance period because of a r...

Lawsuit investigation launched over J.B. Hunt's alleged misleading earnings info causing stock drop
The Rosen Law Firm is investigating potential securities claims against J.B. Hunt Transport Services following a sharp 10% stock drop after the company warned of lower third-quarter earnings due to increased costs. Investors who purchased J.B. Hunt s...

Philips launches HyperVue Integrated System in the U.S. for advanced coronary imaging and physiology in cath labs
Philips has introduced the HyperVue Integrated System in the U.S., a fixed, single-room setup combining DeepOCT+NIRS imaging with X1-FFR physiology assessment for coronary interventions. This system is designed to streamline cath lab workflows by kee...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.